EUVIMEDDécouvrir EUVIMED
CrossrefCarte d’information

Are You Ready to Tackle the Troll? New Guidelines for the Management of Posttransplant Cytomegalovirus Infection

Marcus Pereira

Clinical Transplantation · 2026-11 · 40 (11)

DOI: 10.1111/ctr.70717 ↗
RésuméRéférences bibliographiques

Résumé

ABSTRACT Posttransplant cytomegalovirus (CMV) infection has long been known as the “troll of transplantation”—a hidden threat that can emerge after solid organ transplant (SOT) or hematopoietic cell transplant (HCT) and jeopardize patient well‐being. CMV infection is associated with increased morbidity, mortality, graft loss, and hospitalization, as well as a substantial patient burden that many clinicians may underappreciate. Management becomes even more challenging when infection is refractory or resistant to treatment. To improve outcomes, healthcare professionals must be able to identify patients at risk for CMV infection and refractory/resistant disease, interpret diagnostic findings, apply updated guideline recommendations, and individualize antiviral therapy using current evidence. This comic‐based, expert‐led case activity follows a transplant recipient from the initial presentation of CMV infection through refractory/resistant disease, with patient perspectives woven throughout. Expert faculty perspectives and patient commentary will explore the clinical and psychosocial burden of CMV infection, risk assessment, diagnosis, treatment selection, resistance testing, and shared decision‐making in posttransplant CMV care. To view this activity and obtain CME/CE credit, visit www.cmeologyce.org/cmv .

Des connaissances adaptées à votre travail.

D’un démarrage gratuit à la Research Suite complète, en passant par la recherche bibliographique personnelle.

Voir les tarifs →

Tous les textes intégraux sont-ils inclus ?

Non. Notices, résumés et textes intégraux sont des contenus distincts. La disponibilité dépend de la source, de l’accès ouvert et de vos licences. Une offre EUVIMED ne remplace pas des droits supplémentaires auprès des éditeurs.

Voir les tarifs →